Co-Hosted by:
Course Description
Immerse yourself in groundbreaking advancements in adoptive immunotherapy that are revolutionizing the treatment landscape for hematologic malignancies and beyond.
Join us as we convene esteemed national experts in a forum for collaboration and scientific discourse. Together, we'll delve into basic science and translational research, unlocking the potential of cellular therapeutics for hematologic malignancies, solid tumors, and non-oncologic conditions.
This symposium isn't just about dialogue—it's about shaping the future of medicine. Be part of a transformative journey that transcends boundaries, fosters interdisciplinary partnerships, and propels us closer to the ultimate goal: enhancing patient lives through the power of cellular therapy.
Secure your place at the forefront of medical innovation. Register now and be a catalyst for change.
New this year: The Jonas Center Cellular Therapy Satellite Symposium for Research trainees
-Half-day research symposium geared towards research trainees and fellows
-Delve into the latest advancements, trends, and challenges shaping the field of cellular therapy
-All trainees are encouraged to submit an abstract describing their original basic science or translational cellular therapy research
-Abstracts will be chosen for either oral or poster presentation
September 20, 2024 Agenda
| Time | Agenda |
|---|---|
| 8:00 - 8:30AM | Registration, Exhibit, & Breakfast |
| 8:30 - 8:40AM | Welcome and Introductions Peter Riedell, MD University of Chicago |
| Cellular Therapy in Solid Tumors Faculty moderator: Jeffrey Ward, MD, PhD | |
| 8:40 – 8:45AM | Introduction to Session Jeffrey Ward, MD, PhD Washington University in St. Louis |
| 8:45 – 9:15AM | Unmasking Hidden Targets for Adoptive T Cell Immunotherapy of Ovarian Cancer Kunle Odunsi, MD, PhD University of Chicago |
| 9:15 – 9:45AM | IL13RA2-directed CAR T cells for pediatric brain tumors Leo Wang, MD, PhD City of Hope National Medical Center |
| Janet Rowley Lecture Faculty moderator: John DiPersio, MD, PhD | |
| 9:45 - 9:50AM | Presentation of Janet Rowley Award John DiPersio, MD, PhD Washington University in St. Louis |
| 9:50 - 10:30AM | Janet Rowley Lecture: Avoiding Alloreactive T-cells to Enable Off the Shelf Therapy for Lymphoma Cliona M. Rooney, PhD Baylor College of Medicine |
| 10:30 - 10:50AM | BREAK |
| Overcoming Resistance and Relapse to Cellular Therapy Faculty moderator: Nathan Singh, MD, MS | |
| 10:50 – 10:55AM | Introduction to Session Nathan Singh, MD, MS Washington University in St. Louis |
| 10:55 - 11:25AM | Genetic and Pharmacologic Interventions to Improve CAR T-cell Persistence and Function in Pre-clinical Lymphoma Models Justin Kline, MD University of Chicago |
| 11:25 - 11:55AM | Curing Cancer with CR T-cells: It’s a team effort Joseph Melenhorst, PhD Cleveland Clinic Lerner College of Medicine |
| 11:55 - 1:00PM | LUNCH |
| Time | Agenda |
|---|---|
| Jonas Memorial Lecture Faculty moderator: Michael Bishop, MD | |
| 1:00 - 1:05PM | Presentation of Jonas Memorial Award Michael Bishop, MD University of Chicago |
| 1:05 - 1:45PM | Jonas Memorial Lecture: Molecular Cell Shielding – A Therapeutic Platform Approach for Hematologic Diseases Lukas Jeker, MD, PhD Basel University Hospital and University of Basel |
| Advances in Cellular Therapy Engineering Faculty moderator: James LaBelle, MD, PhD | |
| 1:45 - 1:50PM | Introduction to Session James LaBelle, MD, PhD University of Chicago |
| 1:50 - 2:20PM | In Vivo CAR T-cell generation in non-human primates and tumor-bearing humanized mice using lentiviral particles displaying a multi-domain fusion protein Byoung Ryu, PhD Umoja Biopharma |
| 2:20 - 2:50PM | Using Lipid Nanoparticles to Produce mRNA CAR T Cell Immunotherapies Ann Metzolff, BSE University of Pennsylvania |
| 2:50 - 3:10PM | BREAK |
| Novel Cellular Therapies – From Bench to Bedside Faculty moderator: Justin Kline, MD | |
| 3:10 - 3:15PM | Introduction to Session Justin Kline, MD University of Chicago |
| 3:15 - 3:45PM | Advancing Bispecific LV20.19 CAR T cells at the Medical College of Wisconsin Nirav Shah, MD Medical College of Wisconsin |
| 3:45 – 4:15PM | CAR T-cell Therapy for T-cell Malignancies Armin Ghobadi, MD Washington University in St. Louis |
| 4:15 – 4:45PM | Advancing Cell-Based Cancer Immunotherapy Through Stem Cell Engineering Lili Yang, PhD University of California, Los Angeles |
| 4:45 - 4:50PM | Closing Remarks Faculty moderator: Peter Riedell, MD |
| 4:50 – 6:00PM | Cocktail Reception |
